Jan 17 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd :
* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY
* NEUROMETRIX INC - GSK CONSUMER HEALTHCARE ACQUIRES EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S.
* NEUROMETRIX INC - NEUROMETRIX RETAINS EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY IN U.S. MARKET.
* NEUROMETRIX - CO, GSK CONSUMER HEALTHCARE TO CO-FUND DEVELOPMENT OF QUELL TECHNOLOGY FOR 3 YEARS BEGINNING IN 2018 THROUGH 2020
* NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO $5 MILLION FOR ASSETS RELATING TO QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S
* NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO UP TO $21.5M FOR QUELL UPON ACHIEVEMENT OF CERTAIN MILESTONES Source text for Eikon: Further company coverage:
 